Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marinella Clerico

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Journal of Neurology|September 20, 2005
The importance of maintaining effective therapy in multiple sclerosisLuca Durelli, Marinella Clerico
Brain Sciences|February 27, 2026
The Role of Lifestyle Factors in Multiple Sclerosis: An Integrative PerspectiveRoberta Lanzillo, Marinella Clerico, Saverio Stranges
Expert Opinion on Biological Therapy|March 22, 2007
Interferon-beta1a for the treatment of multiple sclerosisMarinella Clerico, Giulia Contessa, Luca Durelli
Journal of Clinical Medicine|November 25, 2023
Subcutaneous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy: A Historical PerspectiveDario Cocito, Erdita Peci, Maria Claudia Torrieri, et al.
Journal of Clinical Medicine|May 25, 2024
Ultramicronized Palmitoylethanolamide in the Management of Neuropathic Pain Related to Chronic Inflammatory Demyelinating Polyneuropathy: A Proof-of-Concept StudyDario Cocito, Erdita Peci, Maria Claudia Torrieri, et al.
Journal of the Neurological Sciences|March 23, 2007
Adherence to interferon-beta treatment and results of therapy switchingMarinella Clerico, Pierangelo Barbero, Giulia Contessa, et al.
Cells|June 7, 2020
The Meaning of Immune Reconstitution after Alemtuzumab Therapy in Multiple SclerosisSimona Rolla, Alessandro Maglione, Stefania Federica De Mercanti, et al.
International Journal of Molecular Sciences|June 26, 2026
Integrative Transcriptomics Uncovers IFN-β Signature and IFITM3 as Putative Molecular Mediator in MSAlessandro Maglione, Rachele Rosso, Simona Rolla, et al.
Genes|August 27, 2021
Host Genetics and Gut Microbiome: Perspectives for Multiple SclerosisAlessandro Maglione, Miriam Zuccalà, Martina Tosi, et al.
Clinical Neurology and Neurosurgery|January 1, 2008
The therapy of multiple sclerosis with immune-modulating or immunosuppressive drug. A critical evaluation based upon evidence based parameters and published systematic reviewsMarinella Clerico, Chiara Rivoiro, Giulia Contessa, et al.
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Journal of Neurology|September 20, 2005
The importance of maintaining effective therapy in multiple sclerosisLuca Durelli, Marinella Clerico
Brain Sciences|February 27, 2026
The Role of Lifestyle Factors in Multiple Sclerosis: An Integrative PerspectiveRoberta Lanzillo, Marinella Clerico, Saverio Stranges
Expert Opinion on Biological Therapy|March 22, 2007
Interferon-beta1a for the treatment of multiple sclerosisMarinella Clerico, Giulia Contessa, Luca Durelli
Journal of Clinical Medicine|November 25, 2023
Subcutaneous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy: A Historical PerspectiveDario Cocito, Erdita Peci, Maria Claudia Torrieri, et al.
Journal of Clinical Medicine|May 25, 2024
Ultramicronized Palmitoylethanolamide in the Management of Neuropathic Pain Related to Chronic Inflammatory Demyelinating Polyneuropathy: A Proof-of-Concept StudyDario Cocito, Erdita Peci, Maria Claudia Torrieri, et al.
Journal of the Neurological Sciences|March 23, 2007
Adherence to interferon-beta treatment and results of therapy switchingMarinella Clerico, Pierangelo Barbero, Giulia Contessa, et al.
Cells|June 7, 2020
The Meaning of Immune Reconstitution after Alemtuzumab Therapy in Multiple SclerosisSimona Rolla, Alessandro Maglione, Stefania Federica De Mercanti, et al.
International Journal of Molecular Sciences|June 26, 2026
Integrative Transcriptomics Uncovers IFN-β Signature and IFITM3 as Putative Molecular Mediator in MSAlessandro Maglione, Rachele Rosso, Simona Rolla, et al.
Genes|August 27, 2021
Host Genetics and Gut Microbiome: Perspectives for Multiple SclerosisAlessandro Maglione, Miriam Zuccalà, Martina Tosi, et al.
Clinical Neurology and Neurosurgery|January 1, 2008
The therapy of multiple sclerosis with immune-modulating or immunosuppressive drug. A critical evaluation based upon evidence based parameters and published systematic reviewsMarinella Clerico, Chiara Rivoiro, Giulia Contessa, et al.
Pageof 9